Background
Conflicting data exist regarding optimal glycemic control in critically ill trauma patients. We therefore compared glucose parameters and outcomes among three different glycemic control regimens in a single trauma ICU, hypothesizing that a moderate regimen would yield optimal avoidance of hyper- and hypoglycemia with equivalent outcomes when compared to a more aggressive approach.
Methods
We retrospectively reviewed 1422 trauma patients with at least 3-day ICU stay and 5 glucose measurements from May 2001 – January 2010, spanning three non-overlapping, sequential glucose control protocols: ‘relaxed’, ‘aggressive’, and ‘moderate’. For each, we extracted mean blood glucose, hypoglycemic and hyperglycemic event frequency, and glucose variability, and investigated their association with outcomes.
Results
Mortality was associated with elevated mean glucose (135.6 vs. 126.2 mg/dL), more frequent hypoglycemic (2.67 ± 7 vs. 1.28 ± 5) and hyperglycemic (30.6 ± 28 vs. 16.0 ± 22 per 100 patient-ICU-days) events, and higher glucose variability (37.1 ± 20 vs. 29.4 ± 20; all p < 0.001). Regression identified hyperglycemic episodes (p < 0.05) as an independent predictor of mortality. The ‘moderate’ regimen had rare hyperglycemia, low glucose variability, and intermediate mean blood glucose range and frequency of hypoglycemia. Multiorgan failure and mortality did not differ between groups.
Conclusions
Hyperglycemic events (glucose > 180 mg/dL) most strongly predicted mortality. Of glucose control protocols analyzed, the ‘moderate’ protocol had fewest hyperglycemic events. As outcomes were otherwise equivalent between ‘moderate’ and ‘aggressive’ protocols, we conclude that hyperglycemia can be safely avoided using a moderate glycemic control protocol without inducing hypoglycemia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.